FOR IMMEDIATE RELEASE
MESA, Ariz. — December 18, 2025
Dr. Marchand is thrilled to announce that his latest systematic review is now officially published and freely available online today! Titled “Comparison of the Surgical Treatment of Adnexal Masses in Pediatric and Adolescent Patients by Gynecologic Surgeons versus Pediatric Surgeons, a Systematic Review”, this work—led by Greg J. Marchand and colleagues from the Marchand Institute for Minimally Invasive Surgery—provides important insights into optimizing care for young patients with ovarian and adnexal lesions.
The review highlights key advantages when gynecologic surgeons lead these procedures, including significantly lower complication rates, higher rates of ovarian-sparing surgery, fewer conversions from laparoscopy to open surgery, shorter hospital stays, and reduced risk of tumor spillage—while maintaining similar recurrence rates compared to pediatric surgeons. These findings underscore the value of specialized gynecologic expertise in pediatric and adolescent cases, and we believe this work will help guide clinical decision-making and improve outcomes for young patients.
Best of all, the full paper is open access and completely free to read right now. Here are the direct links:
- PubMed (abstract and full-text links): https://pubmed.ncbi.nlm.nih.gov/41409751/
- Free full-text on PubMed Central: https://pmc.ncbi.nlm.nih.gov/articles/PMC12706157/
- Publisher’s site (Dove Press / International Journal of Women’s Health): https://doi.org/10.2147/ijwh.s544674
We invite clinicians, researchers, and anyone interested in pediatric gynecology to dive in and share this important contribution. Thank you for your continued support—excited to see the impact this research will have!
About Dr. Greg Marchand
Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation (EIN 42-2857240). He is Program Director of an SLS-accredited fellowship in Minimally Invasive and Robotic Gynecologic Surgery, holds three issued United States patents, and has served as Principal Investigator on eight FDA clinical trials. His systematic reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised with the Cochrane Risk of Bias 2 tool. He accepts no industry funding for his research.
Media Contact
Maria A. Sainz
Director of Communications and Media Relations
maria@marchandobgyn.com
(480) 999-0905
Newsroom and press kit · Full publication list · Research methodology · Expert commentary topics
###







